Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Exercise × Clear all

Sponsor

Conditions

Motor Activity 7 Neoplasms 4 Breast Neoplasms 4 Multiple Myeloma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Warts 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hematologic Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1 Brenner Tumor 1 Bone Metastases 1 Body Weight 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡